[(18)F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer
Affiliation
Department of Radiation Oncology, The Christie NHS Foundation Trust, Manchester M20 2BX, UK.Issue Date
2024
Metadata
Show full item recordCitation
Bowen Jones S, Cooke S, Belderbos J, Faivre-Finn C. [(18)F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer. The Lancet Oncology. 2024 Nov;25(11):e540. PubMed PMID: 39481410. Epub 2024/11/01. eng.Journal
Lancet OncologyDOI
10.1016/s1470-2045(24)00529-1PubMed ID
39481410Additional Links
https://dx.doi.org/10.1016/s1470-2045(24)00529-1Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/s1470-2045(24)00529-1
Scopus Count
Collections
Related articles
- Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [(18)F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
- Authors: Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P
- Issue date: 2024 Sep
- Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
- Authors: Calais J, Thureau S, Dubray B, Modzelewski R, Thiberville L, Gardin I, Vera P
- Issue date: 2015 Feb
- FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
- Authors: Thureau S, Dubray B, Modzelewski R, Bohn P, Hapdey S, Vincent S, Anger E, Gensanne D, Pirault N, Pierrick G, Vera P
- Issue date: 2018 Oct 23
- Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [(18)F]FDG and [(18)F]Fluoromisonidazole PET/CT in Non-small-cell Lung Cancer Patients.
- Authors: Thureau S, Modzelewski R, Bohn P, Hapdey S, Gouel P, Dubray B, Vera P
- Issue date: 2020 Jun
- Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study.
- Authors: Pommier P, Touboul E, Chabaud S, Dussart S, Le Pechoux C, Giammarile F, Carrie C
- Issue date: 2010 Aug